Further to this, the NYSE, which represents industrials more than biotechs, is down 11.5% over the past week, twice the fall of Acadia.
That certainly doesn’t suggest to me either major concern about COVID-19 impact on clinical trials or the existence of any rumour or leak that the trofinetide trial isn’t progressing well.
NEU Price at posting:
$1.82 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)